Holen Sie sich die Stockscreener-App
754.89
3.91%
28.98
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$725.91
Offen:
$733.05
24-Stunden-Volumen:
361.44K
Relative Volume:
0.75
Marktkapitalisierung:
$60.25B
Einnahmen:
$4.17B
Nettoeinkommen (Verlust:
$1.03B
KGV:
59.84
EPS:
12.6148
Netto-Cashflow:
$940.22M
1W Leistung:
+12.75%
1M Leistung:
+17.70%
6M Leistung:
+50.38%
1J Leistung:
+80.78%
1-Tages-Spanne:
$726.81
$754.60
1-Wochen-Bereich:
$665.25
$754.60
52-Wochen-Spanne:
$356.14
$754.60
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
754.51 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
586.38 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.43 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
152.97 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
227.01 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Idexx Laboratories stock hits all-time high at 735.31 USD By Investing.com - Investing.com Nigeria
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years - Benzinga
Idexx Laboratories stock hits all-time high at 735.31 USD - Investing.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What Are Wall Street Analysts' Target Price for IDEXX Laboratories Stock? - Barchart.com
Can IDEXX Laboratories Inc. (IX1) stock retain market dominanceWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Is IDEXX Laboratories Inc. stock cheap at current valuationJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Why IDEXX Laboratories Inc. stock could benefit from AI revolutionWeekly Trend Summary & Risk Controlled Stock Pick Alerts - newser.com
Is IDEXX Laboratories Inc. stock attractive for ETFsCEO Change & Momentum Based Trading Signals - newser.com
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance
Will IDEXX Laboratories Inc. stock outperform growth indexes2025 Top Gainers & Technical Pattern Based Signals - newser.com
How robust is IDEXX Laboratories Inc. (IX1) stock financial positionWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Why IDEXX Laboratories Inc. stock is a must watch in 2025Portfolio Risk Report & Intraday High Probability Alerts - newser.com
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
IDEXX Laboratories Inc. Stock Climbs 4.0%, Outperforms Peers - 富途牛牛
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Best Manufacturing: IDEXX Horizon Center - Engineering News-Record
Does IDEXX Laboratories Inc. fit your quant trading modelWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Idexx Laboratories Inc-Aktie (IDXX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hunt Nimrata | Executive Vice President |
Nov 07 '25 |
Sale |
703.34 |
9,425 |
6,629,014 |
21,149 |
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):